Priya Singhal - 19 May 2025 Form 4 Insider Report for BIOGEN INC. (BIIB)

Signature
/s/ Samuel Ntonme, attorney-in-fact for Priya Singhal
Issuer symbol
BIIB
Transactions as of
19 May 2025
Net transactions value
-$480,508
Form type
4
Filing time
20 May 2025, 16:05:22 UTC
Previous filing
12 Feb 2025
Next filing
02 Sep 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Singhal Priya Head of Development 225 BINNEY, CAMBRIDGE /s/ Samuel Ntonme, attorney-in-fact for Priya Singhal 20 May 2025 0001769608

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIIB Common Stock Sale $480,508 -3,806 -41% $126.25 5,427 19 May 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Includes 166.6667 shares acquired under the Biogen Inc. employee stock purchase plan on 3/31/2025.